David B. Chapel

MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma

David B. Chapel, Jefree J. Schulte, Kyra B. Berg et al. · Modern Pathology · 2019 · 160 citations · Full text

Engineering, Malignant Disease, Medicine +10

PAX8 Expression in a Subset of Malignant Peritoneal Mesotheliomas and Benign Mesothelium has Diagnostic Implications in the Differential Diagnosis of Ovarian Serous Carcinoma

David B. Chapel, Aliya N. Husain, Thomas Krausz et al. · The American Journal of Surgical Pathology · 2017 · 83 citations

Tumoral Pathology, Medicine, Histopathology +13

An Ovarian Adenocarcinoma With Combined Low-grade Serous and Mesonephric Morphologies Suggests a Müllerian Origin for Some Mesonephric Carcinomas

David B. Chapel, Nancy M. Joseph, Thomas Krausz et al. · International Journal of Gynecological Pathology · 2017 · 71 citations

Ovarian Adenocarcinoma, Tumoral Pathology, Invasive Carcinoma +11

Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center

Françoise Galateau-Sallé, Nolwenn Le Stang, Franck Tirode et al. · Journal of Thoracic Oncology · 2020 · 61 citations · Full text

Tumoral Pathology, Glioma, Medicine +10

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

David B. Chapel, Rachel L. Stewart, Larissa V. Furtado et al. · Human Pathology · 2019 · 55 citations · Full text